News
Bacille Calmette-Guérin revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection.
Bernard emphasized strong performances in the QIAstat Diagnostics and QuantiFERON portfolios, with QIAstat achieving 25% CER ...
Hosted on MSN1mon
Reasons to Retain QIAGEN Stock in Your Portfolio for NowThe QuantiFERON test delivered its sixth consecutive quarter of sales above $100 million, supported by solid demand in all regions from conversion gains against the tuberculin skin test.
The aim of the present work was to evaluate the usefulness of the interferon-gamma release assays (IGRAs): QuantiFERON-tuberculosis (TB) Gold-In-Tube test (QFG) and T-SPOT.TB for the diagnosis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results